Correction: Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial (Trials, (2021), 22, (366), 10.1186/s13063-021-05301-w)

0Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following the publication of the original article [1], we were notified that the reference numbers provided in Table 1 were incorrect. Originally published Table 1: Corrected Table 1: (Table presented.) Measure Time-point* Distress, Frequency and Severity of Voices Outcome Measures Psychotic Symptom Rating Scales – Auditory Hallucinations – a dimensional measure of hallucinations29. Includes Distress dimension (primary outcome), Total score (secondary outcome), and Frequency dimension (secondary outcome)30. Hallucinations Remission Score Screening, 1, 2, 3 Other Voices Outcome Measures Beliefs about Voices Revised (BAVQ-R)32. Voices acceptance and action scale (VAAS)33. First item (power) from the Voice Power Differential Scale34. 1, 2, 3 Experience Sampling Methodology AVATAR2 ESM Questionnaire35. 1,2,3 AVATAR2 ESM Debrief Questionnaire36. 1,2,3 Other Secondary Outcome Measures Mood: Beck Depression Inventory-II37. 1, 2, 3 Anxiety: Depression Anxiety and Stress Scales (DASS-21)38. 1,2,3 Quality of Life: Warwick-Edinburgh Mental Well-being Scale39. 1, 2, 3 Delusions: Psychotic Symptoms Rating Scale (PSYRATS-DEL)29. 1, 2, 3 Service User Led Outcome Measure: Choice of Outcome in CBT for Psychosis (CHOICE) Short Form40. 1,2,3 Trauma related symptoms – International Trauma Questionnaire (ITQ)41. 1, 2 Health Economic Outcome Measures Service use and costs: costs of the intervention (based on staff time, overheads and equipment) and the costs of other key health and social care services calculated using the42. 1, 2, 3 EQ-5D-5L43 to measure QALYs 1, 2, 3 Baseline Clinical Characteristics Voice Characterisation Checklist: Assesses the complexity in characterisation of the dominant voice. Rated as more vs. less highly characterised based on presence/absence of ascribed identity (e.g. known, name), physical characteristics (e.g. age, gender, accent) and psychosocial characteristics (e.g. intentions, thoughts, relationships)-see21. Including two items from the Voice Phenomenology Interview44. 1 Fearful Attachment Style Item from Relationships Questionnaire45. 1 Patient perceived trauma-voice links - Trauma Voice Associations Questionnaire (TVAQ) 1 Trauma history - Mini-Trauma And Life Events (TALE) checklist46. 1 Clinical Assessment Interview for Negative Symptoms (CAINS)47. 1 Identification of positive symptoms – Initial items from the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) 2.148. 1 Detailed assessment of positive symptoms - Scale for the Assessment of Positive Symptoms49. 1 Covid-19 Impact Covid-19 Context Questionnaire to assess individual circumstances during pandemic and change in voice experiences. 1, 2, 3 The original article has been corrected.

Cite

CITATION STYLE

APA

Garety, P., Edwards, C. J., Ward, T., Emsley, R., Huckvale, M., McCrone, P., … Craig, T. (2024, December 1). Correction: Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial (Trials, (2021), 22, (366), 10.1186/s13063-021-05301-w). Trials. BioMed Central Ltd. https://doi.org/10.1186/s13063-024-08549-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free